Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Veterans with heart disease often receive better care through VA than they would elsewhere

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.

  • Read more about Veterans with heart disease often receive better care through VA than they would elsewhere

Opportunistic imaging detects signs of heart disease in lung cancer patients

lung cancer pulmonary nodule

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

  • Read more about Opportunistic imaging detects signs of heart disease in lung cancer patients

LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients

AI artificial intelligence stethoscope doctor

It can be challenging to know which AFib patients are the best candidates for LAAO. A new algorithm out of Mayo Clinic aims to address that problem. 

  • Read more about LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients

FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

the words "FDA recall" on a board

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 

  • Read more about FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

CABG, TAVR top list of most lucrative heart procedures for hospitals

Money dollar investments

Other procedures are associated with higher profits—heart transplants, for instance—but CABG and TAVR are performed much more often.

  • Read more about CABG, TAVR top list of most lucrative heart procedures for hospitals

Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options

Heart cardiologists doctors surgery

A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.

  • Read more about Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options

HeartBeam raising $10M for FDA-cleared health tech with public offering

The FDA recently cleared the company's cable-free, credit card-sized heart monitor that produces 12-lead ECGs.

  • Read more about HeartBeam raising $10M for FDA-cleared health tech with public offering

Johnson & Johnson MedTech launches new large-bore catheter system for stroke

Johnson & Johnson MedTech has launched a new next-generation catheter to be used when treating acute ischemic stroke patients. The Cereglide 92 Catheter System includes a 0.92” catheter as well as the company’s Innerglide 9 deliver aid.

Image courtesy of Johnson & Johnson MedTech.

The next-generation catheter was designed to help clinicians restore blood flow safely and effectively after patients have experienced an acute ischemic stroke. 

  • Read more about Johnson & Johnson MedTech launches new large-bore catheter system for stroke

Use of biolimus-coated balloons during PCI not as effective as paclitaxel devices

doctor wrong patient wrong-site surgery medical error malpractice mistake

Researchers tracked data from more than 200 patients who underwent PCI from August 2020 to July 2022, sharing their findings in JACC: Cardiovascular Interventions.

  • Read more about Use of biolimus-coated balloons during PCI not as effective as paclitaxel devices

Report: Johnson & Johnson wants to sell its stroke business for more than $1B

artificial intelligence money finance acquisition

Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.

  • Read more about Report: Johnson & Johnson wants to sell its stroke business for more than $1B

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …159
    • Page 160
    • Page 161
    • Page 162
    • Current page 163
    • Page 164
    • Page 165
    • Page 166
    • Page 167 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme